In this paper, we consider a tumor growth mathematical model that includes an immune system and drug therapies. Immuno- and chemodrug administration as well as periodic administration of radiation are integrated in the model. We have set an optimal control (OC) problem relative to the model so that the average number of tumor cells and immuno- and chemotherapeutic drug administration are simultaneously minimized in a multiobjective context. The external injection of two immunostimulators and a chemotherapeutic drug has been considered as control, and the objective functionals aim to reflect the severity of both types of drug administration. The multiobjective approach to the OC of the tumor growth model provides good-quality approximate sol...
We investigate a mathematical model of tumor–immune interactions with chemotherapy, and strategies f...
International audienceIn this paper, we investigate a mathematical model describing interactions bet...
In this paper, a therapeutic strategy for the treatment of cancer using immunotherapy that aims to m...
In this paper we compare the dynamics of three tumor growth models that include an immune system and...
We present a competition model of cancer tumor growth that includes both the immune system response ...
We present a competition model of cancer tumor growth that includes both the immune system response ...
We present a competition model of cancer tumor growth which includes both the immune system response...
We investigate a mathematical population model of tumor-immune interactions. The populations involve...
This study addresses a cancer eradication model involving effector cells in the presence of gene the...
In this work we deal with a cancer problem involving the growth of tumor cells and their interaction...
In this work we deal with a cancer problem involving the growth of tumor cells and their interaction...
Interactive dynamics between effector-tumor-normal cells in a mathematical model related to the grow...
A simple mathematical model for the growth of tumour with discrete time delay in the immune system i...
International audienceIn this paper, we investigate strategies for administering chemo-and immunothe...
Abstract. A cell-population based model for tumor growth under anti-angiogenic treatment with the tu...
We investigate a mathematical model of tumor–immune interactions with chemotherapy, and strategies f...
International audienceIn this paper, we investigate a mathematical model describing interactions bet...
In this paper, a therapeutic strategy for the treatment of cancer using immunotherapy that aims to m...
In this paper we compare the dynamics of three tumor growth models that include an immune system and...
We present a competition model of cancer tumor growth that includes both the immune system response ...
We present a competition model of cancer tumor growth that includes both the immune system response ...
We present a competition model of cancer tumor growth which includes both the immune system response...
We investigate a mathematical population model of tumor-immune interactions. The populations involve...
This study addresses a cancer eradication model involving effector cells in the presence of gene the...
In this work we deal with a cancer problem involving the growth of tumor cells and their interaction...
In this work we deal with a cancer problem involving the growth of tumor cells and their interaction...
Interactive dynamics between effector-tumor-normal cells in a mathematical model related to the grow...
A simple mathematical model for the growth of tumour with discrete time delay in the immune system i...
International audienceIn this paper, we investigate strategies for administering chemo-and immunothe...
Abstract. A cell-population based model for tumor growth under anti-angiogenic treatment with the tu...
We investigate a mathematical model of tumor–immune interactions with chemotherapy, and strategies f...
International audienceIn this paper, we investigate a mathematical model describing interactions bet...
In this paper, a therapeutic strategy for the treatment of cancer using immunotherapy that aims to m...